Results 221 to 230 of about 287,918 (287)

CT and MRI Manifestations of Pancreatic Hemangioma: A Literature Review and a New Case Report

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Pancreatic hemangioma is an extremely rare benign tumor occurring in the pancreas. Preoperative diagnosis is challenging due to its lack of specificity in clinical manifestations and imaging examinations. A pancreatic lesion was found during physical examination of a 54‐year‐old woman who had no symptoms of abdominal discomfort.
Jing Zhang   +3 more
wiley   +1 more source

Symptomatic Vulvar Primary Cutaneous Amyloidosis Associated With Low–Risk HPV: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Primary localized cutaneous amyloidosis (PCLA) of the vulva is an infrequent diagnosis. Its clinical presentation may mimic neoplastic or inflammatory lesions and could even be associated with human papillomavirus (HPV) of low or high oncogenic risk, making accurate diagnosis and exclusion of systemic involvement essential. A 73‐year‐old woman
Jorge Hoegl   +3 more
wiley   +1 more source

Ectopic Prostate Tissue in the Bladder Exhibiting Fluorescence on Photodynamic Diagnosis: A Report of Two Cases. [PDF]

open access: yesIJU Case Rep
Shimizu M   +11 more
europepmc   +1 more source

Beyond bacterial defences: the role of lysozyme in cancer

open access: yesClinical and Translational Medicine, Volume 16, Issue 2, February 2026.
Lysozyme (LYZ) is a multi‐functional secreted factor that encompasses both antibacterial and immunomodulatory functions. Emerging evidence highlights its complex role in tumour progression by directly influencing tumour cells and modulating the immune microenvironment.
Lei Wang   +4 more
wiley   +1 more source

Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting

open access: yesClinical and Translational Medicine, Volume 16, Issue 2, February 2026.
This review systematically deconstructs the pathological efferocytic—metabolic axis in tumours, framing it as a three‐stage, self‐reinforcing cycle: from metabolite‐driven macrophage recruitment, through hijacked surface recognition, to post‐phagocytic metabolic reprogramming that locks in immunosuppression.
Qianlu Yang, Jie Yan, Qianxi Yang
wiley   +1 more source

Glucose-transporter 1 (GLUT1) as a prognostic biomarker: evidence from 14,966 human tumors across 134 cancer types. [PDF]

open access: yesBMC Cancer
Büyücek S   +27 more
europepmc   +1 more source

Performance of Two‐Tiered Subclassification of Atypia of Undetermined Significance in Thyroid Fine‐Needle Aspiration Without Routine Molecular Testing

open access: yesDiagnostic Cytopathology, Volume 54, Issue 2, Page 78-86, February 2026.
ABSTRACT Background The third edition of the Bethesda system for reporting thyroid cytopathology recommends a simplified two‐tiered subclassification of atypia of undetermined significance (AUS), dividing cases into AUS with nuclear atypia (AUS‐Nuclear) and other atypia (AUS‐Other).
Pocholo D. Santos   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy